Senior Director Biotechnology and Biotech-Services @ (March 2024 - April 2025)
VP, Data Integrity Officer and Chief of Staff to the COO @ (May 2023 - February 2024)
Head of Biosimilar Quality at Alvotech @ (January 2021 - May 2023)
Director Site Quality Head Bio MS and T and Contract Manufacturing Organisations, Bio CMO Ops. @ (April 2016 - January 2021)
Head of QA Auditing and CMO Surveillance @ (January 2014 - April 2016)
QA Manager Audits @ (August 2012 - January 2014)
QA Manager @ (August 2010 - July 2012)
CAPA Manager (QA) @ (February 2009 - July 2010)
Martin Baur Education
Universität St.Gallen (HSG), Executive School, Law & Management
CAS General Management
2025-2026
Hochschule Furtwangen University
Dipl. Ing. (Biotechnology)
2005-2009
Martin Baur Skills
Biotechnology
FDA GMP
Auditing
USP
DSP
Sterile and Aseptic Fill and Finish
Quality Assurance
QC
Biopharmaceuticals
cGMP manufacturing
cGMP practices
CCIT
Troubleshooting
CAPA
Change Control
Deviation Management
OOS
CMO management
Team Leadership
ANVISA
CMO overseight
GMP
FDA
Pharmaceutical Industry
Validation
SOP
Technology Transfer
Regulatory Affairs
Life Sciences
Quality System
21 CFR Part 11
R&D
Quality Control
Regulatory Submissions
Contract Negotiation
Microsoft Excel
Process Improvement
Sterile and Aseptic
Martin Baur Summary
Martin Baur, based in Germany, is currently a VP Corporate Development Biopharmaceuticals Technical Operations at Midas Pharma. Martin Baur brings experience from previous roles at Midas Pharma and Alvotech. Martin Baur holds a 2025 - 2026 CAS General Management @ Universität St.Gallen (HSG), Executive School, Law & Management. With a robust skill set that includes Biotechnology, FDA GMP, Auditing, USP, DSP and more. Martin Baur has 1 emails on RocketReach.
Looking for a different Martin Baur?
Find contact details for 700 million professionals.